Immediate Impact

4 by Nobel laureates 18 from Science/Nature 58 standout
Sub-graph 1 of 24

Citing Papers

Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia
2025 Standout
Toward Multi-Targeted Platinum and Ruthenium Drugs—A New Paradigm in Cancer Drug Treatment Regimens?
2019 Standout
2 intermediate papers

Works of J. C. Byrd being referenced

Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retrospective comparative analysis of CALGB 9712 and CALGB 9011
2004

Author Peers

Author Last Decade Papers Cites
J. C. Byrd 177 317 127 264 10 644
Efterpi Kostareli 95 217 135 167 17 707
Gerald W. King 56 87 184 78 16 668
Konstantinos Gkouvatsos 228 214 128 27 13 676
G Deb 104 111 206 40 15 616
André Sels 29 201 238 45 18 616
Julie Fuller 13 157 125 113 19 525
Mairéad Reidy 123 49 324 78 14 661
Andreas Due Ørskov 96 49 271 83 18 544
Elmer B. Brown 156 132 159 20 22 635
Jean‐Claude Sibille 112 84 154 16 8 545

All Works

Loading papers...

Rankless by CCL
2026